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Abstract 
The literature has suggested that menopause symptoms are conveniently divided into two groups: these are 
psychological symptoms associated with immediate or eminent cessation of menses, and those physiological 
symptoms which appear after some years of menopause. The purpose of this study was to construct an inventory 
based on psychological and physiological symptoms which appear after some years of menopause, to obtain 
test-retest reliabilities of items and to factor analyze the instrument to empirically investigate the two-type of 
menopause. The first set of 550 items had mean test-retest reliabilities of 0.76 and yielded two clearly distinct 
factors in support of the two-type hypotheses. When items with factor loadings less than ±0.35 were discarded, 
250 items remained and the mean test-retest reliabilities of these items was 0.78.Again, the 250 items in the 
second phase was reduced to 110 items in the third phase which now yielded two clearly distinct factors 
defining psychological and physiological symptoms consistent with the literature yielded test-retest reliabilities 
of 0.87. The retained items from the first inventory and the items from the second and third inventory loaded on 
the same factors all the times. It was concluded that two types of menopause symptoms do, in fact exist and that 
this study has provided a reliable means of differentiating them. 
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1. Introduction 
Menopause literally means the "end of monthly cycles" (the end of monthly periods menstruation), from the 
Greek word pausis (cessation) and the root mean- (month). Menopause is an event that typically (but not 
always) occurs in women in midlife, during their late 40s or early 50s, and it signals the end of the fertile phase 
of a woman’s life [22]. However, rather than being defined the absence of menstrual flow, menopause is more 
accurately defined as the permanent cessation of the primary functions of the ovaries: the ripening and release of 
ova and the release of hormones that cause both the creation of the uterine lining, and the subsequent shedding 
of the uterine lining (the menses or the period) [11]. The indication of this is equivalent to retirement from 
menstrual flow and in a way stoppage of reproductive systems.  
Transition from a potentially reproductive to a non-reproductive state is the result of a reduction in female 
hormonal production by the ovaries [5] which is normally not sudden or abrupt, but tends to occur over a period 
of years,  as a consequence of biological aging. However, for some women, the accompanying signs and effects 
that can occur during the menopause transition years can significantly disrupt their daily activities and sense of 
well-being. The functional disorders often significantly speed up the menopausal process and create more 
significant health problems, both physical and emotional, for the affected women [23]. Menopause has a wide 
starting range, but can usually be expected in the age range of 42– 45 [5]. Meanwhile, an early menopause can 
be related to cigarette smoking, higher body mass index, racial and ethnic factors, illnesses, chemotherapy, 
radiation and the surgical removal of the ovaries, with or without the removal of the uterus. In his own opinion 
[19] asserted that menopause can be officially declared (in an adult woman who is not pregnant, is not lactating, 
and who has an intact uterus) when there has been amenorrhea (absence of any menstruation) for one complete 
year. 
Reference [17] observed the following as preceding the cessation of menses, irregular menses, vasomotor 
instability (hot flashes and night sweats), atrophy of genitourinary tissue, increased stress, breast tenderness, 
vaginal dryness, forgetfulness, mood changes, and in certain cases osteoporosis and/or heart disease. According 
to them, these effects are related to the hormonal changes a woman's body is going through, and they affect each 
woman to a different extent. The only sign or effect that all women universally have in common is that by the 
end of the menopause transition every woman will have a complete cessation of menses .This in essence 
indicates that menopause varies from individual to individual and it also depends on a number of factors 
including the onset of menarche as an adolescent. In Nigeria, the most typical age range for menopause (last 
period from natural causes) is between the ages of 40 and 61 and the average age for last period is 51 year [2],  
although this varies considerably from one woman to another [26]. Women who have undergone hysterectomy 
with ovary conservation go through menopause on average 3.7 years earlier than the expected age. 
Peri-menopause which literally means ‘’around menopause’’ precedes the menopause proper and is the 
transition from reproductive life to menopause, characterized by irregularities in menstrual cycle. Average age is 
45 to 47, but may occur as early as 35. Some hallmark symptoms of peri -menopause include; shortening of 
menstrual cycle, shorter or longer duration of bleeding, heavier bleeding, increased mood disturbances, 
sleeplessness, or hot flashes. Two things that may influence the age of onset of natural menopause are smoking 
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and genetics. Daughters tend to experience menopause at nearly the same age as their mothers. This span of 
time is also commonly called the change of life, the change, or the climacteric.  
The fluctuations in the hormone level of estrogen is what causes many physical changes during perimenopause 
as well as menopause [24]. Some of these changes are hot flashes, night sweats, difficulty sleeping, vaginal 
dryness or atrophy, incontinence, osteoporosis and heart disease. During this period, fertility diminishes, but is 
not considered to reach zero until the official date of menopause. The official date is determined retroactively, 
once 12 months have passed after the last appearance of menstrual blood. Signs and effects of the menopause 
transition can begin as early as age 35, although most women become aware of the transition in their mid to late 
40s, often many years after the actual beginning of the perimenopausal window.  
The duration of perimenopause with noticeable bodily effects can be as brief as a few years, but it is not unusual 
for the duration to last ten or more years. The actual duration and severity of perimenopause effects for any 
individual woman currently cannot be predicted in advance. Even though the process or the course of 
perimenopause or menopause can be difficult to predict, often the age onset is somewhat predictable. Women 
often, but not always will start this transitions (perimenopause and menopause) about the same time as their 
mom [3]. 
Hot flashes can be so strong that they raise the body temperature by many degrees in a very short period of time; 
this extreme temperature differential can cause the sufferer to feel weak and break out in heavy sweating. 
Despite the discomfort to the woman, hot flashes are not considered harmful by physicians. Many women 
manage hot flashes by dressing in ways that dissipate heat quickly (natural fibers, loose clothing, easily 
removable layers of lightweight garments) as well as mechanical means which help the body to remove excess 
heat, such as fans, drinking ice water, and staying in cool rooms [10]. Other common effects encountered during 
the peri -menopausal period include mood changes, insomnia, fatigue, and memory problems. Menopause may, 
in some women, bring about a sense of loss related to the end of fertility. In addition this change often occurs at 
a time of life when other stressors may be present in the life of a woman.  
Post  -menopause is thus all of the time in a woman's life that take place after her last period, or more accurately, 
all of the time that follows the point when her ovaries become inactive [22]. The reason for this delay in 
declaring a woman postmenopausal is because periods are usually extremely erratic at this time of life, and 
therefore a reasonably long stretch of time is necessary to be sure that the cycling has actually ceased 
completely. At this point a woman is considered infertile, and no longer needs to consider the possibility of 
becoming pregnant. However the possibility of becoming pregnant has usually been very low (but not zero) for 
a number of years before this point is reached [14]. 
Reference [11] stated the effects of menopause as including formication (crawling, itching, or tingling skin 
sensations), which may be associated directly with hormone withdrawal. Both users and non-users of hormone 
replacement therapy identify lack of energy as the most frequent and distressing effect [13]. Other effects can 
include vasomotor symptoms such as hot flashes and palpitations, psychological effects such as depression, 
anxiety, irritability, mood swings, memory problems and lack of concentration, and atrophic effects such as 
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vaginal dryness and urgency of urination. 
The average woman also has increasingly erratic menstrual periods, due to skipped ovulations. In addition the 
duration of the flow may be considerably shorter or longer than normal, and the flow itself may be significantly 
heavier or lighter than was previously the case, including sometimes long episodes of spotting. Early in the 
process it is not uncommon to have some 2-week cycles. Further into the process it is common to skip periods 
for months at a time, and these skipped periods may be followed by a heavier period [19]. At the point when a 
woman of menopausal age has had no periods or spotting for 12 months, she is considered to be one year into 
post-menopause.  
According to [12] menopause was found to be associated with hot flashes; joint pain and muscle pain; and 
depressed mood . Menopause was found not to be associated with poor sleep, decreased libido, and vaginal 
dryness. However, in contrast to this, it was found to have association with poor sleep quality [7]. Menopause 
symptoms are conveniently divided into two groups: those acute (psychological) symptoms associated with 
immediate or eminent cessation of menses, and those later (physiological), symptoms which appear after some 
years of menopause. However, it is believed that three symptoms may be regarded as truly related to 
menopause. The purpose of this study therefore is to attempt to develop local   instrument create for 
understanding of signs and symptoms of Menopause as many of such instruments available are foreign ones. 
1.1 Hypotheses 
In order to establish the psycho-metric properties of this inventory, the following null hypotheses were 
formulated and tested. 
H1: Psychological and physiological symptoms will not differ significantly in the women experiencing 
menopause. 
H2: The reliability and distribution of the scores will not indicate that MSI possess psychometric capable of 
differentiating between the two types of menopause. 
H3: The type of menopause symptoms chosen by the participants will not correlate with the three factors pattern 
of unrotated MSI factors to evaluate interrelationships among the items. 
H4: The ranked scores of the items will not reveal a relatively continuous dimension between acute and later 
symptoms of menopause. 
1.2 Methodology 
The menopause symptoms inventory a psychometric test to differentiate between the two types of menopause 
was constructed by: 
1) Developing items from the literature that characterized the symptoms i.e. (acute (psychological) and later 
294 
International Journal of Sciences: Basic and Applied Research (IJSBAR) (2015) Volume 24, No  2, pp 291-305 
 
(physiological) symptoms. 
2) Administering and factor analyzing these items on three separate samples. 
Step 1 
For the administration of the inventory to the first sample 550 items were developed from symptoms of the two 
types of menopause discussed in the literature. The 550 items were statements about symptoms with five 
response choices reflecting the degree to which the symptom is present for the participants and would select one 
of five alternative responses most descriptive of her. The final item had only two response choices. This item 
asked whether or not the participants was taking hormonal prescriptive, including oral contraceptives before the 
cessation of their menses. The participants constituting the first sample were 200 volunteer female teachers from 
3 different schools in Ibadan North Local Government Area of Oyo State who described themselves as 
menopausal individuals. These participants were given the 550-item inventory once at the beginning and again 
at the end of a 2-week period. 
 After this inventory was given the second time, the participants were asked to indicate on their inventory the 
type that best described their experience with menopausal symptoms. The purpose of the two administrations for 
the first sample was to yield test-retest reliability of the items which was 0.76 after subjecting it to Pearson 
Product Moment Correlation Coefficient. Factor analysis was performed on the results of the second 
administration. 
 Step II 
Two types of menopause symptoms emerged from and were defined by the factor analysis of the data from 
administration of the inventory to the first sample. This inventory was then revised by eliminating those items 
which were not correlated with the factors, and by rewriting items for increased clarity. The resulting, revised 
inventory had 250items).  One hundred and twenty-five (125) of these 250 items were statements about 
symptoms with five response choices reflecting the degree to which the symptom is present for the participants 
completing the inventory. 
 One hundred and twenty-five (125) of these 250 items were characteristics of acute (psychological) symptoms 
and One hundred and twenty-five (125) characteristics of later (physiological) symptoms of menopause. This 
revised inventory was administered to a second sample to examine whether or not the items would continue to 
be reliable, and would continue to generate the same factors item inventory. The participants in the second 
sample were 165 female teachers from three different secondary schools in Akinyele Local Government Area of 
Oyo State who described themselves as having menopause symptoms, and who had not participated in the 
previous administrations of the 550-item inventory. These participants were given the 250-item inventory once 
at the beginning and again at the end of a 2-week period. 
This 250-item inventory was scored so that each participant was given a score of 1-5 for each item. The score of 
5 was assigned when participants responded to ‘always’ experiencing a symptom characteristic of acute 
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(psychological) menopause symptoms. A score of 1 was assigned if participants responded to ‘never’ 
experiencing this symptom. Conversely, a score of 1 was assigned if participants responded to ‘always’ 
experiencing a symptom characteristic of later (physiological) menopause symptoms; and a score of 5 was 
assigned if another participant responded to ‘never’ experiencing this symptom. Thus, the 125 items describing 
symptoms characteristic of later (physiological) menopause were scored in reverse order to those of later 
(physiological) menopausal stage. In this phase a correlation coefficient of 0.78 was obtained after processing 
the data collected with (PPMC). The scores of 2,3 and 4were assigned in order to correspond to the scoring 
pattern described above. 
 Step 111  
From the responses obtained at the second step of the development of (MSI –R), the researcher further subject 
the items to qualitative and quantitative analysis using Item Discrimination (ID) Technique.  Thus, the 250 items 
at the steps II were reduced to 160 divided into psychological and physiological symptoms. These items were 
also given to test experts and psychologist for validation. They were further reduced to 110 items that finally 
made up the MSI –R.  These were eventually tested on 80 menopausal women in Oyo East Local Government 
Area. The internal consistency correlation co-efficient of the inventory was established using responses obtained 
from step III. The response was subjected to Pearson Product Moment Correlation Coefficient Reliability which 
yielded .933 and coefficient Alpha of .87.  The highest possible score was 550 and the lowest possible score was 
110. 
The Inventory 
Menopause Symptoms Inventory- Revised is a psychological and physiological instrument that contains 55 
structured items of psychological symptoms and 55 items of physiological symptoms. The responses to the 
items are graded on a 5-point likert format. 
Table 1: Internal Consistency Values of Menopause Symptoms Inventory- Revised 
Items Inter- Item R.I (T-I) Items Inter- Item R.I (T-I) 
1. .6320 56. .5563 
2. .4961 57. .5591 
3. .5348 58. .6598 
4. .6235 59. .7332 
5. .6354 60. .6380 
6. .6969 61. .5959 
7. .6704 62. .5745 
8. .7222 63. .6492 
9. .7226 64. .6217 
10. .6903 65. .6338 
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11. .5510 66. .4389 
12. .6772 67. .6991 
13. .6363 68. .6727 
14. .7234 69. .5337 
15. .6363 70. .7674 
16. .7234 71. .7223 
17. .5739 72. .5316 
18. .5216 73. .5992 
19. .5443 74. .5453 
20. .6217 75. .5818 
21. .5121 76. .4671 
22. .6532 77. .7916 
23. .6827 78. .6067 
24. .6623 79. .6365 
25. .5681 80. .5634 
26. .5492 81. .5161 
27. .6540 82. .7453 
28. .6489 83. .7317 
29. .7857 84. .7101 
30. .4365 85. .5949 
31. .5719 86. .5627 
32. .5064 87. .6939 
33. .6517 88. .4536 
34. .4623 89. .6653 
35. .5313 90. .6712 
36. .6142 91. .6003 
37. .4903 92. .5339 
38. .5717 93. .6720 
39. .6218 94. .7567 
40. .7235 95. .7329 
41. .7162 96. .7033 
42. .6663 97. .6731 
43. .5412 98. .7844 
44. .5864 99. .4555 
45. .4608 100. .6937 
46. .7219 101. .6531 
47. .6967 102. .5182 
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48. .5731 103. .5729 
49. .7553 104. .6915 
50. .5277 105. .5364 
51. .4393 106. .7217 
52. .6509 107. .6921 
53. .6848 108. .5863 
54. .5163 109. .6535 
55. .6290 110. .5159 
Equal Length Spearman – Brown      = .7391 
Unequal Length Spearman – Brown = .7533 
Guttmann Split Half =    .7769 
Coefficient Alpha =    .7925  
Table 2: Factor pattern of the three unrotated MSI-R factor 
Items Factor 1 Factor 2 Factor 3 H2 
1. -0.241 0.676 -0.287 0.674 
2. 0.590 0.319 0.366 0.538 
3. 0.189 0.505 -0.298 0.384 
4. 0.438 0.318 0.344 0.409 
5. 0.319 0.514 0.316 0.467 
6. 0.579 -0.267 -0.230 0.455 
7. 0.622 -0.248 0.322 0.550 
8. 0.416 -0.289 -0.313 0.356 
9. -0.268 0.565 0.294 0.477 
10. 0.499 -0.284 -0.212 0.368 
11. 0.247 0.486 0.357 0.419 
12. 0.588 0.317 0.327 0.548 
13. 0.300 0.484 0.320 0.426 
14. 0.596 0.230 0.396 0.560 
15. 0.470 -0.278 0.412 0.461 
16. -0.211 0.590 -0.019 0.395 
17. 0.256 0.496 -0.236 0.365 
18. 0.610 -0.277 0.401 0.614 
19. 0.344 0.434 0.346 0.430 
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20. 0.320 0.580 0.350 0.563 
21. 0.522 0.316 0.327 0.477 
22. 0.270 0.469 -0.249 0.350 
23. 0.237 0.412 0.300 0.312 
24. 0.488 -0.249 -0.273 0.366 
25. 0.596 -0.597 0.387 0.865 
26. 0.632 0.503 -0.217 0.671 
27. 0.513 0.319 0.461 0.583 
28. 0.419 -0.276 0.293 0.382 
29. 0.537 -0.291 0.346 0.406 
30. 0.461 0.468 0.311 0.472 
31. 0.585 0.371 0.315 0.453 
32. 0.569 0.320 0.292 0.551 
33. -0.286 0.593 0.218 0.352 
34. 0.491 0.287 0.375 0.473 
35. 0.372 0.694 0.329 0.386 
36. 0.271 0.422 0.369 0.491 
37. 0.553 -0.229 0.421 0.518 
38. 0.641 0.579 -0.039 0.462 
39. 0.597 0.393 -0.236 0.506 
40. 0.313 0.233 0.407 0.416 
41. -0.417 0.483 0.351 0.359 
42. 0.611 0.515 0.327 0.365 
43. 0.337 0.363 -0.273 0.641 
44. 0.417 0.541 0.387 0.403 
45. 0.343 0.592 0.313 0.536 
46. 0.627 0.534 0.316 0.417 
47. 0.631 0.436 -0.213 0.310 
48. 0.540 0.363 0.357 0.322 
49. 0.484 -0.217 0.396 0.367 
50. 0.439 0.381 0.402 0.651 
51. -0.219 0.411 0.353 0.413 
52. 0.616 0.372 0.294 0.533 
53. 0.573 0.329 0.289 0.427 
54. -0.243 0.667 -0.237 0.473 
55. 0.289 0.391 0.316 0.352 
56. 0.438 0.513 0.478 0.465 
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57. 0.317 0.381 0.692 0.433 
58. 0.597 0.517 0.605 0.465 
59. 0.614 0.367 0.477 0.526 
60. 0.461 -0.251 0.600 0.363 
61. -0.263 -0.298 0.631 0.561 
62. 0.492 0.655 0.578 0.491 
63. 0.274 -0.248 0.568 0.432 
64. 0.303 0.468 0.619 0.624 
65. -0.212 0.319 0.567 0.574 
66. 0.271 0.448 0.446 0.359 
67. 0.237 0.231 0.239 0.423 
68. 0.512 -0.279 0.432 0.487 
69. 0.481 0.509 0.410 0.610 
70. 0.611 0.469 0.408 0.588 
71. 0.407 -0.273 0.637 0.413 
72. 0.569 0.443 0.577 0.625 
73. 0.309 0.508 0.617 0.456 
74. -0.213 0.361 0.464 0.522 
75. 0.331 0.496 0.391 0.411 
76. 0.342 0.416 0.322 0.373 
77. -0.266 -0.294 0.513 0.418 
78. 0.329 0.579 0.291 0.316 
79. 0.414 0.433 0.311 0.545 
80. 0.529 0.510 0.415 0.635 
81. 0.515 0.513 0.514 0.617 
82. 0.412 0.667 0.435 0.617 
83. 0.591 0.531 0.557 0.568 
84. 0.384 0.554 0.510 0.484 
85. 0.513 -0.261 0.591 0.411 
86. 0.695 0.336 0.471 0.477 
87. 0.362 0.565 0.568 0.451 
88. 0.418 0.482 0.493 0.553 
89. -0.286 0.319 0.664 0.553 
90. 0.439 0.482 0.372 0.647 
91. 0.274 0.330 0.328 0.536 
92. 0.566 0.627 0.537 0.541 
93. 0.303 0.509 0.648 0.624 
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94. 0.516 0.694 0.511 0.650 
95. 0.433 -0.279 0.595 0.514 
96. -0.201 0.438 0.496 0.539 
97. 0.266 0.550 0.420 0.416 
98. 0.613 0.613 0.449 0.340 
99. 0.431 0.429 0.379 0.563 
100. 0.302 0.421 0.301 0.547 
101. 0.519 -0.243 0.432 0.503 
102. 0.276 0.537 0.414 0.312 
103. 0.372 0.511 -0.276 0.514 
104. 0.581 0.444 0.563 0.527 
105. 0.615 0.422 -0.236 0.514 
106. 0.482 0.327 0.492 0.422 
107. 0.369 0.447 0.443 0.497 
108. 0.503 0.529 0.513 0.413 
109. 0.662 0.318 0.431 0.540 
110. 0.577 0.416 0.551 0.532S 
Total Variance 
accounted for 
33.741 25.923 11.463 71.127 
Eigen values 5.717 2.991 1.005 
 
 
Table 3: List of ranked scores obtained from second pilot administration of MSI-R 
Items Ranked Scores Items Ranked Scores 
1. 510 41. 394 
2. 508 42. 393 
3. 508 43. 390 
4. 506 44. 386 
5. 506 45. 384 
6. 503 46. 380 
7. 503 47. 372 
8. 503 48. 370 
9. 503 49. 366 
10. 499 50. 362 
11. 498 51. 360 
12. 496 52. 350 
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13. 496 53. 344 
14. 496 54. 342 
15. 492 55. 340 
16. 485 56. 338 
17. 480 57. 332 
18. 480 58. 330 
19. 472 59. 328 
20. 470 60. 320 
21. 465 61. 318 
22. 452 62. 312 
23. 448 63. 310 
24. 448 64. 308 
25. 440 65. 300 
26. 440 66. 295 
27. 440 67. 292 
28. 436 68. 290 
29. 436 69. 288 
30. 425 70. 284 
31. 425 71. 280 
32. 425 72. 276 
33. 425 73. 273 
34. 425 74. 270 
35. 418 75. 265 
36. 410 76. 263 
37. 410 77. 260 
38. 402 78. 255 
39. 400 79. 252 
40. 398 80. 
 
   
N= 80 
2. Results 
2.1 Hypotheses Testing 
In this section of the paper, results of analysis of research hypotheses are presented. The 110-item inventory first 
underwent a correlational analysis to examine the reliability of the items over the 2-week period of time. All 
items yielded reliability coefficients equal to or greater than0.600 and the average coefficient based on Z-score 
transformation was 0.76. Following this correlational analysis, a principle components factor analysis [16] was 
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performed on the second administration of the inventory. This was to examine whether or not participants were 
responding differently to those items, theoretically characteristic of later (physiological) menopause symptoms. 
The requirement that a factor possess an Eigen value greater than 1 was the criterion for the number of factors 
(of a limit of ten) was considered. Using this criterion, the first three factors were extracted from the correlations 
among items. These three factors accounted for 42.57 percent of the data’s variance, while the other factors 
accounted for an additional 10.46 percent of the total variance. Those items with factor loading greater than ± 
0.350 were assigned to one of the three factors. For those items meeting this criterion, the highest loading 
determined the factor to which the item was assigned. Using this procedure, no items were assigned to the third 
factor and 140 items which did not meet criterion were eliminated. The items which were assigned to the first 
factor were all characteristic of acute psychological symptoms of menopause while those items which were 
assigned to the second factor were all characteristic of later (physiological) symptoms of menopause. 
3. Discussion and conclusions  
This edition is a response to the client’s observation and sensitivity to the yearnings of the therapists. Thus, the 
former 25 Menopause Symptoms Questionnaire  (MSQ) is further developed through literature review and the 
fact that clients complained that some of the items lumped together, may not occur at the same time, inspire the  
author to   extensively review current  and recent literature on  menopause and generated and validated   
additional items to read the current 110 items. The extraction of the two factors, the reliability of the items and 
distribution of the scores into two groups all suggest that the MSI has a psychometric capable of differentiating 
the two types of menopause symptoms. This finding is important for three reasons. First, it substantiates [15] 
assertion that there are two types of menopause symptoms – acute symptoms associated with immediate or 
eminent cessation of menses and those later symptoms which appear after some years of menopause.  
Second, because the two types manifests at different times and require different treatments, it may be necessary 
to determine client’s type of symptom. Third, MSI allows reliable and efficient differentiation between the two 
types of symptoms for future research on therapy tailored to each type, of symptom, acute (psychological) and 
later (physiological) symptoms. One such possible treatment is behaviour modification, which has been shown 
to be an effective therapy for acute (psychological) symptoms of menopause might be further explored as a 
treatment which may be more effective with one of the two types of the symptoms. Research has suggested that 
one of the physiological effects of muscle relaxation treatment is a reduction [18]. If, as asserted by [13]  the 
discomfort in menopause symptoms is related to acute symptoms such as insomnia, the hot flush while the later 
symptoms is related to decline in physical and mental energy, profound sweating, then Stress Inoculation 
Training (SIT) may be more effective with acute  psychological symptoms. Further research is necessary to 
ascertain whether the pairing of muscular relaxation with the onset of menopause would lead to an alleviation of 
the discomfort experience by women with acute (psychological) menopause symptoms. 
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